Evaluating Orally Administered Meloxicam-Loaded Polymeric Nanocapsules in Female Dogs: A Population Pharmacokinetic Modeling Study

<b>Background/Objectives</b>: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently administered prophylactically to mitigate postoperative pain; however, its utility is limited by characteristic NSAID-associated adverse...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Flávia Elizabete Guerra Teixeira, Graziela de Araújo Lock, Renata Giacomeli, Camila de Oliveira Pacheco, Tamara Ramos Maciel, Ana Pozzato Funghetto-Ribeiro, Gabriela Lugoch, Diego Vilibaldo Beckmann, Marília Teresa de Oliveira, Sandra Elisa Haas
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2026-03-01
Sarja:	Pharmaceuticals
Aiheet:	NSAIDs dogs nanocapsules population pharmacokinetic modeling
Linkit:	https://www.mdpi.com/1424-8247/19/3/412
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!